Twelve-month extension study to evaluate the long-term durability of RP-G28 on a subset of Phase 2b/3 clinical trial patients with lactose intolerene

Trial Profile

Twelve-month extension study to evaluate the long-term durability of RP-G28 on a subset of Phase 2b/3 clinical trial patients with lactose intolerene

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 19 Nov 2016

At a glance

  • Drugs RP G28 (Primary)
  • Indications Lactose intolerance
  • Focus Therapeutic Use
  • Sponsors Ritter Pharmaceuticals
  • Most Recent Events

    • 19 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top